 |
 Inventors and founders of Lytix Biopharma in NRK’s Schrödingers Katt. Watch the programme in Norwegian. |
|
|
 Leaders in synthetic micropeptides Lytix Biopharma AS is a privately-owned pharmaceutical company focussed on anti-microbials and cancer therapeutics. The Company develops novel drugs for the treatment of resistant bacterial and fungal infections, as well as first-in-class oncology treatments. Selective, ultra-rapid membrane disruption  Time 0 min 5 min 10 min 20 min |
|
 Tromsø, Norway, and Seoul, Korea, June 18, 2009:
- Lytix Biopharma and KAEL–GemVax announce joint clinical trialJune 02, 2009:
- North Murray AS has exercised warrant.March 24, 2009:
- Lytix Biopharma has issued shares and a warrant directed at North Murray AS / Gert W. MuntheFebruary 26, 2009:
- 8 new job openings. We will expand our team of drug development professionals in support of the ... |
||||
